Table 4.
Characteristics of studies included in the meta‐analysis (correlation of Yes‐associated protein [YAP] expression in hepatocellular carcinoma with clinicopathological features)
| Study | YAP (−) | YAP (−) | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Sex (M/W) | Vascular invasion (Y) | Cellular differentiation (L) | Tumour Size (>5 cm) | TNM (I + II) | AFP (>400 ng/mL) | Tumour number (>1) | Hepatitis (Y/N) | AJCC (I) | ||
| Lei (2015) | 10 | 8/2 | 4 | N | N | N | 5 | N | N | 1 |
| Li (2015)25 | 51 | 49/2 | 14 | 5 | 21 | N | 18 | 21 | 51 | 19 |
| Han (2014)5 | 12 | 10/2 | 3 | 1 | 5 | 5 | N | 2 | 7 | N |
| Xu (2009)11 | 67 | 53/14 | 31 | 9 | N | N | 13 | 17 | 46 | 29 |
| Wu (2016)23 | 59 | 50/9 | 12 | N | 24 | 18 | N | N | 56 | N |
| Wang (2016)7 | 25 | 22/3 | 3 | 6 | N | N | N | 15 | 23 | N |
| Xu (2013)9 | 98 | 90/8 | 24 | 23 | 34 | 83 | N | 20 | 97 | N |
| Liu (2015)12 | 29 | N | 7 | 1 | N | 28 | 14 | N | N | N |